[Form 4] Resideo Technologies, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Michael Carlet, Chief Financial Officer of Resideo Technologies, Inc. (REZI), reported a sale of 2,334 shares of the company's common stock on 08/15/2025 at a price of $31.60 per share. Following this transaction he beneficially owned 158,527 shares. The Form 4 was signed by an attorney-in-fact on 08/19/2025.

Insights

Financial Analyst

TL;DR: Insider sale of 2,334 shares, leaving 158,527 shares owned; routine disclosure with limited investor impact.

The reported sale is a small, non-derivative disposition by the CFO and does not include any accompanying commentary about intent or plans. The transaction size relative to total reported holdings appears modest and there are no derivative or exercise events disclosed. This Form 4 documents compliance with Section 16 reporting requirements rather than signaling a material corporate change.

Corporate Governance Expert

TL;DR: Properly executed Form 4 filing for an officer sale; disclosure appears complete and timely.

The form identifies the reporting person, relationship to the issuer as CFO, the transaction date, transaction code and price, and the post-transaction beneficial ownership. The signature by an attorney-in-fact is provided. There are no indications of rule 10b5-1 plan filings or additional agreements in this filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Carlet Michael

(Last) (First) (Middle)

16100 N 71ST STREET

SUITE 550

(Street)

SCOTTSDALE AZ 85254

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
RESIDEO TECHNOLOGIES, INC. [ REZI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/15/2025		F		2,334	D	$31.6	158,527	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Jeannine J. Lane, as Attorney-in-Fact for Michael Carlet	08/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did REZI CFO Michael Carlet report on Form 4?

He reported a sale of 2,334 shares of Resideo common stock on 08/15/2025 at $31.60 per share.

How many shares did Michael Carlet own after the reported transaction?

Following the sale he beneficially owned 158,527 shares.

When was the Form 4 for Michael Carlet signed and by whom?

The Form 4 was signed by Jeannine J. Lane, as Attorney-in-Fact on 08/19/2025.

Was the reported transaction a derivative transaction or a non-derivative transaction?

The filing shows a non-derivative common stock transaction (a sale).

Does the Form 4 mention a 10b5-1 trading plan?

No. The filing does not indicate that the transaction was made pursuant to a 10b5-1 plan.